Abstract
Deep brain stimulation (DBS) of the ventralis intermedialis nucleus of the thalamus (VIM) for essential tremor (ET) is recommended for medication-refractory patients with significant tremor that impacts on activities of daily living or quality of life. Patients should be made fully aware of the potential benefits and complications of surgery and that their expectations are realistic. The most important issues regarding DBS are that the diagnosis is correct, that the patient has had an adequate trial of medical therapy, and that the odds of improvement are substantial when weighed against the risks. Consideration must also be given to physical, psychological, and socioeconomic issues. The potential of DBS to keep patients employed and functioning socially should be the highest priority. Although VIM DBS is the surgical treatment of choice in ET, newer ablative approaches, such as focused ultrasound, should be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Feket R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry. 2014;85:567–72.
Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, Sperling SA, Wang XQ, Gwinn R, Witt J, Ro S, Elias WJ. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: A Randomized Clinical Trial. JAMA Neurol. 2017.
Borretzen MN, et al. Long-term follow-up of thalamic deep brain stimulation for essential tremor-patient satisfaction and mortality. BMC Neurol. 2014;14:120.
Elble J. The essential tremor syndromes. Curr Opin Neurol. 2016;29:507–12.
Favilla CG, et al. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain. 2012;135:1455–62.
Favilla CG, Topiol DD, Zesiewicz TA, Wagle Shukla A, Foote KD, Jacobson CE 4th, Okun MS. Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation. Parkinsonism Relat Disord. 2013;19:171–5.
Munhoz R, Picillo M, Fox S, Bruno V, Panisset M, Honey C, Fasano A. Eligibility criteria for deep brain stimulation in Parkinson’s disease, tremor, and dystonia. Can J Neurol Sci. 2016;43:462–71.
Picillo M, Fasono A. Recent advances in essential tremor: surgical treatment. Parkinsonism Relat Disord. 2016;22:S171–5.
Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D. Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it? Parkinsonism Relat Disord. 2013;19:676–9.
Shukla AW, Okun M. State of the art for deep brain stimulation therapy in movement disorders: a clinical and technological perspective. IEEE Rev Biomed Eng. 2016;9:219–32.
Zappia M, Albanese A, Bruno E, Colosimo C, Filippini G, Martinelli P, Nicoletti A, Quattrocchi G, Abbruzzese G, Berardelli A, Allegra R, Aniello MS, Elia AE, Martino D, Murgia D, Picillo M, Squintani G. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol. 2013;260:714–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
DeLong, M.R. (2019). Treatment of Essential Tremor: Deep Brain Stimulation. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_40
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_40
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)